Not available
Quote | Mersana Therapeutics Inc. (NASDAQ:MRSN)
Last: | $1.83 |
---|---|
Change Percent: | 0.0% |
Open: | $1.84 |
Close: | $1.83 |
High: | $1.89 |
Low: | $1.76 |
Volume: | 814,301 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Mersana Therapeutics Inc. (NASDAQ:MRSN)
2024-05-20 16:47:47 ET Gainers: Maravai LifeSciences ( MRVI ) +5% . Caribou Biosciences ( CRBU ) +4% . Greenidge Generation Holdings ( GREE ) +4% . Cipher Mining ( CIFR ) +4% . SIGA Technologies ( SIGA ) +4%...
2024-05-15 09:56:00 ET Summary Mersana Therapeutics, Inc. is a cancer-focused biotech with two pipeline projects in phase 1 clinical study. Their lead compounds, XMT-1660 and XMT-2056, target novel immune checkpoints and HER2, respectively. The company has enough cash to suppo...
Message Board Posts | Mersana Therapeutics Inc. (NASDAQ:MRSN)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $MRSN 46% v15,6M C6.40 f109,069M H6.71 ML3.68 RL4.27 gapNgo S@6 | znewcar1 | investorshangout | 05/04/2023 3:45:42 AM |
Price trading last up | jaybe | investorshub | 04/30/2023 7:14:44 PM |
$MRSN Price gaining last up | dorothy52 | investorshub | 04/30/2023 1:10:48 PM |
what do you make of this data? | jaybe | investorshub | 04/30/2023 1:01:14 AM |
The now last trade up | TrendTrade2016 | investorshub | 04/29/2023 2:21:40 AM |
News, Short Squeeze, Breakout and More Instantly...
Mersana Therapeutics Inc. Company Name:
MRSN Stock Symbol:
NASDAQ Market:
Mersana Therapeutics Inc. Website:
Maximum tolerated dose not yet established in Phase 1 clinical trial of XMT-1660; enrollment in dose escalation and backfill cohorts continuing in parallel; expect to announce initial clinical data and initiate expansion in the second half of 2024 Patient recruitment ongoing in Phase 1 cl...
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that ...
2024-03-18 08:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...